Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome - Summary - MDSpire

Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome

  • June 5, 2026

  • 0 min

Share

Objective:

To report the retraction of the original research article due to concerns regarding data validity raised by the authors.

Key Findings:
  • The authors did not provide raw data or a satisfactory explanation during the investigation.
  • The editors lost confidence in the findings presented in the article due to the unresolved concerns.
Interpretation:

Limitations:
  • The authors did not provide raw data as requested during the investigation.
  • Concerns regarding the validity of the data were not satisfactorily addressed during the investigation.
Conclusion:

The article was retracted due to the lack of sufficient data support and unresolved concerns about the findings.

Original Source(s)

Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome

  • June 5, 2026

Related Content

Ovarian intelligence: AI applications leveraging AMH and inhibin B

Autoimmune Disorders Among Patients with Varied Phenotypes of Polycystic Ovary Syndrome

Clinical efficacy of acupuncture for women with PCOS undergoing IVF/ICSI: a meta-analysis of randomized controlled trials